^{Note: The scenario below is illustrative. It is based on common challenges Genista helps supplement brands navigate. Specific details, timelines, and outcomes are representative of real program types, not a single documented customer story.}

The email arrived on a Tuesday. A major natural grocery retailer had reviewed the brand. They loved the pitch and the product, and were interested in moving forward.

But, before the follow-up meeting, the buyer needed one thing. They needed a complete testing document package that measured potency, purity, label accuracy, and accredited COAs for every active SKU.

The brand had 30 days.

The problem: they did not have any of it.

The gap most emerging brands do not know they have

This brand was not cutting corners. They had a quality program. They tested their products in their contract manufacturer's in-house lab. This is common for brands at their stage.

Most brands do not find this gap until a retailer asks a question the brand cannot answer. The question was simple: does the laboratory hold ISO/IEC 17025 accreditation, and are the relevant methods within its accredited scope?

The answer was no.

Contract manufacturer labs are often competent. But competent is not the same as independently verified.

Some retail buyers may require results from an independent accredited laboratory, depending on their program and product requirements. Label claim accuracy and contamination risk are under close regulatory and consumer review.

When a retailer requires accredited independent testing, the supporting documentation becomes part of the qualification process.
‍

The question was not whether their product was safe. It was whether they could prove it to someone with no reason to take their word for it.‍

‍

What 30 days actually looked like

In this scenario, the brand comes to Genista with a clear task – to run the full test suite on their top SKUs. Deliver accredited COAs. And, do it all before the buyer meeting.

Here is what the illustrative timeline could look like from intake to result:

• Days 1-2: Sample intake and panel selection. We reviewed every active SKU. We matched the right panels to each product label. Panels included potency, purity, label accuracy, heavy metals, microbiology, and allergen screens.
  ‍
• Days 3-5: Sample processing. High-throughput robotic automation processed all SKUs at the same time. There were no bottlenecks. We did not wait for one panel to finish before starting the next.
  ‍
• Days 6-12: Analysis and review. Real-time PCR, analytical chemistry, and microbiology panels ran at the same time. Qualified scientists reviewed each result against the applicable label claims and regulatory criteria.
  ‍
• Day 13: First results delivered. COAs were prepared. Chain of custody documents were completed for the first group of SKUs.
  ‍
• Day 21: Full test package complete. Every active SKU was tested. All COAs from the accredited laboratory were ready. Documents were formatted for retailer submission.

In this illustrative timeline, the package is complete nine days before the deadline.

By the numbers:

100% of SKUs tested  •  21-day turnaround vs. 60+ days at traditional labs  •  Retailer account secured

‍

What the testing could reveal

Most results came back clean but not all of them. Two SKUs show label accuracy discrepancies. The declared potency on the label did not match the analytical result.

This was not a safety issue, it was a compliance issue. A retailer or regulatory review could raise questions about the discrepancy.

The brand had two options. They could reformulate before the buyer meeting. Or they could update the label to show the actual potency.

They chose to update the label. They worked with their regulatory team and filed the updated label. They walked into the buyer meeting with accurate documents.

Finding the discrepancy before the meeting gives the brand time to address it.

A label problem found in a retailer audit after placement means a corrective action. It may mean a delisting, and it may create a brand reputation problem. If found before placement, it is fixable.

‍

Why this pattern is common

This type of documentation gap can emerge during retail expansion. It is widely common for most emerging supplement and food brands when they begin retail expansion.

The testing gap exists for a clear reason. Brands build quality programs around production, not around retail qualification. 

They test what they need to manufacture safely. They do not always test what a major retailer's quality team will require, not until the retailer asks.

Brands that handle retail expansion well close this gap before the buyer meeting, not during it.

They build accredited independent testing into their quality program early. The documents exist when needed, not built under a deadline.

The cost of doing this early is predictable. The cost of doing it late is higher. The cost of not doing it is losing an account or damaging the brand’s reputation.

‍

What a retail-ready test package requires

For supplement brands, a complete retail-ready test package includes:

• Potency testing: verify active ingredient levels against label claims using validated analytical methods
• Purity testing: confirm the absence of contaminants, adulterants, and undeclared substances
• Microbiology: run pathogen screening and total aerobic count for the product category
• Heavy metals: screen for lead, arsenic, cadmium, and mercury against California Prop 65 and USP limits
• Allergen screens: confirm that undeclared allergens are absent at detection limits
• Label accuracy: compare declared amounts on the label against analytical results

Every panel must come from an ISO/IEC 17025-accredited laboratory that uses methods validated for your specific product. The lab must document the chain of custody from sample receipt to result delivery.

A defensible COA reflects both the reported result and the documented process behind it.

‍

The bottom line

Shelf placement at a major natural grocery retailer is one of the most valuable outcomes for a supplement brand.

The brands that get there and stay there have documents that hold up to review. Not just at the buyer meeting but in every audit, every renewal, and every regulatory review that follows.

Accredited testing is not the finish line. It is the foundation of everything that follows.

The point of this illustrative scenario is not that testing guarantees a retail account. It is that accurate, complete documentation can help a brand enter the review process prepared.